Sustainable Growth Opportunities in the Glufosinate Market

By -

The glufosinate market is estimated to be valued at USD 1.37 Billion in 2016, and is projected to grow at a CAGR of 9.25% from 2016 to 2022.

Glufosinate Market

(EMAILWIRE.COM, February 06, 2020 ) The Report "Glufosinate Market by Crop Type (Genetically Modified Crops, Conventional Crops), Form (Liquid Formulation, Dry Formulation), Application (Agricultural, Non Agricultural), and Region - Global Forecast to 2022", is projected to reach USD 2.34 Billion by 2022. The glufosinate market is estimated to be valued at USD 1.37 Billion in 2016, and is projected to grow at a CAGR of 9.25% from 2016 to 2022. Glufosinate are widely accepted in agricultural and non-agricultural applications and play a vital role in weed controlling. Its usage is growing in recent years because it is considered as a suitable substitute for glyphosate and paraquat. The proportion of glyphosate-resistant weeds has been growing over the past few years because of its extensive usage. Farmers consider glufosinate as a better alternative in the non-selective herbicides market to protect and maintain crop yield. Furthermore, the USFDA considers glufosinate as a safer option compared to other herbicides available in the U.S. market such as paraquat. Hence, glufosinate should be viewed as a business opportunity in the next five years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191789620

On the basis of crop type, the global market is segmented into genetically modified crops and conventional crops. The genetically modified crops dominated the market owing to its major use in the production of various products and wider availability. Genetic modified techniques are widely used to make crops herbicide-resistant.

The global glufosinate market, on the basis of application, is segmented into agricultural and non-agricultural applications. The demand for glufosinate is expected to increase in the next few years due to the growing yield of agricultural crops such as corn, soybean, beans, canola, sugar beets, sugar cane, and sweet potato that are genetically modified to tolerate glufosinate. The grains & cereals segment accounted for the largest market share in 2015.

The forms of glufosinate considered for the study are liquid and dry. Liquid formulation of glufosinate is widely used as it has low temperature stability as compared to dry formulations, which has a long process of usage.

Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=191789620

In 2015, the North American region accounted for the largest share of the global glufosinate market in terms of value and volume. The glufosinate market in North America is also projected to grow at a significant CAGR during the forecast period. This region comprises developed economies such as U.S. and Canada, where the U.S. is a key producer of various agricultural applications. There is growing awareness observed in the U.S. with regard to glufosinate products. Glufosinate is registered for use in crops such as almonds, apples, bananas, berries, canola, corn, cotton, grapes, potatoes, rice, soybean, and tree nuts in the U.S. which has resulted in the growth of the market in this region.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as Bayer AG (Germany), The Dow Chemical Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Syngenta AG (Switzerland), and UPL (India).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more